Eiger Biopharmaceuticals shares owned by Jpmorgan Chase & Co
Quarter-by-quarter ownership of Eiger Biopharmaceuticals shares owned by Jpmorgan Chase & Co
from 13F filings
Historical chart of Jpmorgan Chase & Co investment in Eiger Biopharmaceuticals
Tip: Access up to 7 years of quarterly data
All positions including Eiger Biopharmaceuticals held by Jpmorgan Chase & Co consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Eiger Biopharmaceuticals by Jpmorgan Chase & Co
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2023-12-31 | $37 | 166 | 0.22 |
| 2023-09-30 | $2.6k | 8.4k | 0.30 |
| 2023-06-30 | $101k | 144k | 0.70 |
| 2023-03-31 | $178k | 199k | 0.90 |
| 2022-12-31 | $133k | 113k | 1.18 |
| 2022-06-30 | $722k | 115k | 6.29 |
| 2022-03-31 | $930k | 112k | 8.30 |
| 2021-12-31 | $599k | 115k | 5.21 |
| 2021-03-31 | $1.1M | 128k | 8.85 |
| 2020-12-31 | $2.5M | 204k | 12.29 |
| 2020-09-30 | $1.7M | 201k | 8.27 |
| 2020-06-30 | $3.0M | 311k | 9.60 |
| 2020-03-31 | $2.0M | 294k | 6.80 |
| 2019-12-31 | $4.9M | 332k | 14.84 |
| 2019-09-30 | $3.2M | 308k | 10.25 |
| 2019-06-30 | $340k | 32k | 10.69 |
| 2019-03-31 | $688k | 49k | 13.99 |
| 2018-09-30 | $927k | 77k | 12.00 |
| 2018-06-30 | $462k | 38k | 12.19 |
| 2017-12-31 | $180k | 13k | 13.94 |
| 2017-06-30 | $23k | 3.0k | 7.78 |
| 2017-03-31 | $32k | 2.8k | 11.61 |
| 2016-12-31 | $44k | 3.8k | 11.66 |